39-amino-acid triple receptor agonist (GIP/GLP-1/glucagon) — studied in cutting-edge metabolic-receptor research.
Select size
Quantity
Retatrutide is a relatively new research peptide and one of the most pharmacologically interesting incretin-class molecules. It's a 39-amino-acid synthetic peptide that hits three different receptors at once — GIP, GLP-1, and the glucagon receptor — making it a "triple agonist." It also carries a fatty-acid tag that helps it stick around longer in lab conditions.
How it's been studied: Cell-culture and animal-model research has examined Retatrutide's combined activity at three receptors that together govern insulin release, food-intake signaling, and energy expenditure. It's frequently studied side-by-side with single-agonist (GLP-1 only) and dual-agonist (GIP+GLP-1) peptides for comparison. Although clinical research exists, this product is research-use-only.
Where you'll see it in research:
Handling notes: The fatty-acid tag gives it longer in vitro stability via albumin binding. Standard peptide handling otherwise.
Every batch is third-party tested for purity, identity, and contaminants. Download the COA for the lot you receive.
10mg
10mg
1mg
Stack Total
$354.00
Molecular Weight
≈ 4731 g/mol
Form
Lyophilized powder
Storage
Lyophilized: 2-8°C up to 24 months. Reconstituted: 2-8°C, use within 30 days.
Sequence
39-AA modified GIP/GLP-1/glucagon agonist
All compounds are sold individually and do not include reconstitution supplies, syringes, or aliquoting tools. Products ship in lyophilized (freeze-dried) form and require proper reconstitution before use in research settings. See our Reconstitution Solution page for laboratory-grade bacteriostatic water.
Research use only — not for human or animal consumption. See our Research Use Disclaimer.
